United States
Award-winning medical sales leader with 15+ years of success driving growth across pharmaceuticals, medical devices, diagnostics, and capital equipment. Recognized for consistent top-tier performance, market-shaping product launches, and converting complex accounts into long-term partnerships. I thrive at the intersection of clinical excellence and business outcomes, helping practices improve patient care while maximizing profitability. Known for resilience, adaptability, and a leadership style built on urgency, agility, and accountability, I deliver measurable results in competitive and evolving healthcare markets. 💡 What I Bring to the Table • Align clinical solutions with business outcomes, delivering both improved patient care and stronger profitability • Proven success in competitive markets, consistently outperforming targets, ranking in the top tier nationwide • Expertise in first-in-class product launches, drugs, devices, capital equipment and diagnostics • Trusted relationship builder and credibility with physicians, executives, and healthcare decision makers • Strategic and adaptable leader thriving in startups, growth stage, and Fortune 500 environments 🏆 Key Achievements • Ranked in the top 10–20% nationally across multiple companies by exceeding quota year after year • Closed $1.5M+ private equity and IDN conversions, creating lasting enterprise adoption • Generated $300K+ annual sales and set a company record with a $75K multi-facility conversion • Successfully launched presbyopia therapies, mydriasis drug/device combos, and osmolarity diagnostics into competitive markets • Managed and grew territories worth $500K–$1.5M, building market share and physician loyalty • Earned repeated top national rankings with Bausch & Lomb, Abbott, Sanofi, and other industry leaders I bring relentless drive, strong physician relationships, and a “never over promise, only over deliver” mindset. This commitment has defined my career and continues to fuel measurable growth, trusted partnerships, and lasting impact across competitive healthcare markets.
Exceeded Quota 2018 • 2018 35% Increase in Q3/Q4 sales within first 5 months • 2019 Top 20% - Overall Power Rank 8 / 60 Promote an ophthalmic treatment medical device (Avenova) for Dry Eye Disease as it relates to targeted accounts in the glaucoma, retina, cornea, ocular plastics, pediatric and general ophthalmology specialties as well as medically focused Optometrists Strategically leverage (Buy and Sell), indirect (Rx), and hybrid sales channels to achieve regional quota attainment. Call points included: High volume M.D./O.D. Practices, teaching institutions, C.E. event promotional vendor events, and referrals for dry eye focused doctors Accomplishments: - Developed, and pending approval a Regional partnership with the largest optometric group in Arizona and New Mexico - American Vision Partners. The goal was Avenova to be placed in locations via Buy and Bill for pre/post op therapy for for those with dry eyes, blepharitis, and meibomian gland dysfunction.
Exceeded Quota 2016, 2017, 2018 • 2017 - Top 20% - Overall Power Rank 40 / 167 • 2016 - Top 15% - Overall Power Rank 21 / 167 • 2015 - 15% Increase in Q4 sales within first 3 months Responsible and managed $1M territory for medical device sales of disposable contact lenses directly to doctors of Ophthalmology and Optometric practices in a consultive selling approach throughout Arizona.